Ontario Brain Institute

By 2030, nearly 1 million Canadians could be living with dementia. Supporting an aging, at-risk population means planning now, with diagnostic technology that makes dementia care arrive earlier, faster, and more personalized.

Blood-based biomarker (BBM) testing could be that solution. BBMs are quickly being adopted into clinical practice worldwide.

That's why OBI is partnering with Alzheimer Society of Ontario and the Weston Brain Institute on the Canada Blood-based Biomarkers Readiness & Pathway Development initiative. Guided by experts, patient partners, and advocates, the project will inform a coordinated, evidence-based approach to BBM use across Canada's dementia care system.

A $200K investment from the Weston Family Foundation helps make this work possible. We're honoured to partner with two leaders in brain health to accelerate responsive, innovative dementia care.

🔗 Learn more: https://westonfoundation.ca/weston-brain-institute/

Accessibility looks like technology that fits every child's needs — not the other way around.

Trexo Robotics builds wearable robotic devices that support over-ground walking for children with physical and neurological conditions. The Trexo device is adjustable and customizable, supporting walking both at home and in clinical settings, bringing this technology directly to the children and families who need it.

OBI supported Trexo Robotics early on through the 2017 NERVE program. Since then, hundreds of children across Canada have used the device, and the company has twice been named to the Forbes Accessibility List. Trexo is now being evaluated as a clinical tool with backing from Hamilton Health Sciences Foundation and OBIO's LSCTC Centre of Excellence.

➡️ Learn more about Trexo and book an in-home trial: https://www.trexorobotics.com/about-us/

About Us Trexo's story started when Manmeet learned his nephew would not be able to walk due to cerebral palsy and decided to build him a robotic exoskeleton suit.